Literature DB >> 1800705

Synthesis, antitumor activity, and nephrotoxicity of the optical isomers of 2-aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)platinum(II).

K Morikawa1, M Honda, K Endoh, T Matsumoto, K Akamatsu, H Mitsui, M Koizumi.   

Abstract

The optical isomers of 2-aminomethylpyrrolidine(1,1-cyclobutane- dicarboxylato)platinum(II) (DWA2114, 1), which has potent antitumor activity against various tumors, were synthesized. They were examined for antitumor activity against Colon 26 carcinoma in a sc-iv system, and changes in urinary protein and sugar levels in drug-treated mice were used as an index of nephrotoxicity. In their effect on tumors, (+)-(S)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato++ +)platinum(II) (6b) was more potent than the enantiomer 6a in that the effective dose of 6b was smaller than that of 6a; but, both drugs exhibited potent antitumor activity. On the other hand, a distinct difference between 6a and 6b was shown in their nephrotoxicity. Isomer 6b induced a great increase in urinary protein and sugar levels in mice, whereas 6a caused no increase in these levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1800705     DOI: 10.1002/jps.2600800907

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Solvation of platinum anti-cancer drugs in methanol-water mixtures.

Authors:  J Burgess; D N Drasdo; M S Patel
Journal:  Biometals       Date:  1995-04       Impact factor: 2.949

2.  Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.

Authors:  K Kamisango; T Matsumoto; K Akamatsu; K Morikawa; T Tashiro; K Koizumi
Journal:  Jpn J Cancer Res       Date:  1992-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.